Streetbeat News

Earnings

GHLD

Guild Holdings (GHLD) reported Q4 2023 adjusted EPS of $0.20, surpassing the $0.14 estimate, but its sales of $57.234M fell short of the $172.681M estimate, marking a 57.38% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:09 pm

MXCT

MaxCyte (NASDAQ:MXCT) reported Q4 earnings with losses of $(0.05) per share, surpassing the $(0.07) estimate, and sales of $15.66M, exceeding the $13.09M estimate. This represents a 26.09% increase in sales compared to the same period last year.

Portfolio Pulse from Happy Mohamed

March 12, 2024 | 8:08 pm

PFMT

Performant Financial (PFMT) reported Q4 2023 adjusted EPS of $0.05, surpassing the $0.01 estimate, and sales of $32.567M, exceeding the $31.587M estimate. This represents a 400% increase in EPS and an 11.37% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:08 pm

FTK

Flotek Industries (NYSE:FTK) reported Q4 2023 earnings of $0.07 per share, missing the consensus estimate of $0.08. Quarterly sales were $42.188M, below the $47.250M estimate, marking a 12.50% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:07 pm

PRPL

Purple Innovation projects its FY24 revenue to be in the range of $540M-$560M, which is around the current estimate of $546.53M.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:07 pm

GHLD

Guild Holdings (GHLD) reported its Q4 2023 adjusted earnings per share (EPS) of $0.20, surpassing the analyst consensus estimate of $0.14 by 42.86%.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:07 pm

WEST

Westrock Coffee (NASDAQ:WEST) reported Q4 sales of $214.97M, missing the consensus estimate of $226.02M by 4.89%, marking a 5.60% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:07 pm

PRPL

Purple Innovation (PRPL) reported Q4 2023 adjusted EPS of $(0.15), surpassing the $(0.18) estimate. Sales reached $145.900M, slightly above the $145.565M forecast, marking a 0.53% year-over-year increase.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:06 pm

SURG

Surgepays reported its Q4 2023 earnings with a GAAP EPS of $0.19, missing the consensus estimate of $0.41 by 53.66%. Quarterly sales were $32.318M, also below the estimate of $33.521M by 3.59%, marking a 10.79% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:06 pm

ICAD

icad (NASDAQ:ICAD) reported Q4 2023 adjusted EPS of $(0.02), surpassing the $(0.05) estimate, with sales of $4.741M exceeding the $4.300M forecast. This represents a significant improvement in losses per share compared to the same period last year, but a decrease in sales.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:06 pm